X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2898) 2898
male (1909) 1909
female (1857) 1857
adult (1715) 1715
gastroenterology & hepatology (1459) 1459
index medicus (1396) 1396
middle aged (1332) 1332
hepatitis b (1321) 1321
hepatitis b e antigens - blood (1286) 1286
hepatitis b, chronic - drug therapy (1281) 1281
hepatitis b virus - genetics (1234) 1234
antiviral agents - therapeutic use (1124) 1124
hepatitis b virus (975) 975
dna, viral - blood (826) 826
lamivudine (785) 785
hepatitis b, chronic - virology (769) 769
e-antigen (755) 755
treatment outcome (727) 727
hepatitis (690) 690
hepatocellular-carcinoma (644) 644
adolescent (640) 640
interferon (626) 626
infection (620) 620
hepatitis b e antigen (619) 619
virology (612) 612
seroconversion (590) 590
chronic hepatitis b (578) 578
hepatitis b virus - immunology (569) 569
aged (543) 543
therapy (536) 536
alanine transaminase - blood (530) 530
hepatitis b, chronic - immunology (519) 519
genotype (517) 517
mutation (505) 505
lamivudine - therapeutic use (487) 487
hepatitis b e antigens - immunology (482) 482
infectious diseases (469) 469
hepatitis b e antigens - analysis (460) 460
hepatitis b surface antigens - blood (451) 451
viral load (448) 448
interferon-alpha - therapeutic use (447) 447
antigens (440) 440
dna (440) 440
hepatitis b, chronic - blood (428) 428
virus-infection (418) 418
hepatitis b - immunology (403) 403
health aspects (399) 399
e-antigen seroconversion (393) 393
hepatitis b virus - drug effects (393) 393
young adult (391) 391
natural-history (383) 383
follow-up studies (364) 364
child (348) 348
adefovir dipivoxil (344) 344
hepatitis b surface antigen (338) 338
surface-antigen (338) 338
entecavir (332) 332
deoxyribonucleic acid--dna (330) 330
hepatitis b virus - isolation & purification (323) 323
time factors (316) 316
liver (312) 312
cirrhosis (306) 306
guanine - analogs & derivatives (295) 295
retrospective studies (293) 293
care and treatment (285) 285
digestive system diseases (280) 280
virus diseases (280) 280
risk factors (276) 276
dna, viral - analysis (275) 275
infections (274) 274
adenine - analogs & derivatives (272) 272
analysis (269) 269
mutations (264) 264
antiviral agents - administration & dosage (263) 263
hepatitis b - virology (261) 261
gastroenterology and hepatology (260) 260
risk (257) 257
drug therapy, combination (254) 254
dna, viral - genetics (246) 246
guanine - therapeutic use (243) 243
hepatology (241) 241
hepatitis b, chronic - complications (240) 240
patients (240) 240
hbeag (239) 239
hepatitis b antibodies - blood (239) 239
hepatitis b, chronic - diagnosis (239) 239
hbv (236) 236
hepatocellular carcinoma (236) 236
polymerase chain reaction (236) 236
antiviral agents (233) 233
pharmacology & pharmacy (228) 228
hepatitis b - drug therapy (227) 227
adenine - therapeutic use (226) 226
prospective studies (225) 225
management (223) 223
hepatitis b virus - physiology (221) 221
tenofovir (220) 220
hepatitis b surface antigens - analysis (219) 219
genotypes (217) 217
genetic aspects (215) 215
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3187) 3187
Chinese (79) 79
Korean (30) 30
Japanese (19) 19
German (15) 15
Spanish (14) 14
Polish (10) 10
French (9) 9
Russian (6) 6
Croatian (2) 2
Czech (2) 2
Italian (2) 2
Danish (1) 1
Dutch (1) 1
Hungarian (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Viral Hepatitis, ISSN 1352-0504, 07/2019, Volume 26, Issue 7, pp. 828 - 834
Summary Hepatitis B e antigen (HBeAg) seroconversion experienced during nucleo(s)tide analogue (NUC) therapy is often not sustained. We aimed to study whether... 
entecavir | hepatitis B core‐related antigen | HBeAg seroconversion | nucleo(s)tide analogues | tenofovir | hepatitis B core-related antigen | HBCRAG | INFECTIOUS DISEASES | VIROLOGY | GASTROENTEROLOGY & HEPATOLOGY
Journal Article
Journal Article
Journal Article
Journal of Viral Hepatitis, ISSN 1352-0504, 08/2018, Volume 25, Issue 8, pp. 886 - 893
Summary HBeAg seroconversion marks an important spontaneous change and treatment end‐point for HBeAg‐positive patients and is a pre‐requisite for HBsAg loss or... 
nucleos(t)ide analogue | hepatitis B core‐related antigen | hepatitis B e antigen seroconversion | hepatitis B surface antigen | Hepatitis B | hepatitis B core-related antigen | ENTECAVIR | 5-YEAR | INFECTIOUS DISEASES | CHRONIC HEPATITIS-B | CORE-RELATED ANTIGEN | HEPATOCELLULAR-CARCINOMA | THERAPY | VIROLOGY | DNA | SURFACE-ANTIGEN | GASTROENTEROLOGY & HEPATOLOGY | TENOFOVIR
Journal Article
Journal of Viral Hepatitis, ISSN 1352-0504, 12/2019, Volume 26, Issue 12, pp. 1473 - 1480
Hepatitis B core‐related antigen (HBcrAg) is a novel serological marker for hepatitis B virus infection. Its clinical significance after HBeAg seroconversion... 
chronic hepatitis B | hepatitis B core‐related antigen | cirrhosis | hepatocellular carcinoma
Journal Article
Journal Article
Journal of Viral Hepatitis, ISSN 1352-0504, 01/2019, Volume 26, Issue 1, pp. 126 - 135
Summary Nucleos(t)ide analogues (NA) are effective in suppressing hepatitis B virus (HBV) replication, but most patients require long‐term treatment. This... 
clinical trial | hepatitis cure | nucleotide analogue | hepatitis B surface antigen | hepatitis B e antigen | ALPHA-2A | INFECTIOUS DISEASES | GUIDELINES | FOLLOW-UP | RISK | LAMIVUDINE THERAPY | DURABILITY | TENOFOVIR DISOPROXIL FUMARATE | VIROLOGY | INFECTION | HBEAG-POSITIVE PATIENTS | GASTROENTEROLOGY & HEPATOLOGY
Journal Article
Journal Article